Patient Access Insights

Innovation tools for Market Access

In this webinar, the panel of experts discuss different innovation tools and how to harness digital systems to find new levels of patient value.
Register here

Innovation tools for Market Access

When: Tuesday 22nd September 2020 at 12:30 – 14:00 BST

Learning objectives:

  •  Examine approaches to utilising Real World Evidence (RWE)

  •  Guidance on collaborative working and horizon scanning

  •  Discuss the NHS Long Term Plan and what this means for pharma companies

  •  Harness digital systems and technology to find new levels of patient value

  •  Understand the benefits of using research tools for market access

Who would benefit from registering to attend this webinar:

This webinar should be attended by representatives from UK, European and global pharmaceutical, biotech, life science and MedTech industries, as well as patient organisations and patient groups.

The job functions that will benefit most include:

• Heads of Market Access

• Managing Directors

• Country Managers

 • Chief Executives

• Health Economists

• Medical Directors

• Commercial Directors

• Policy Officers/Executives

• Marketing Directors

• Policy Advisors


Speaker%20picture%20 %20Andi%20Orlowski

Andi Orlowski, Head of Business Intelligence, Imperial College Healthcare Partners

Andi is a health economist and leads the business intelligence function at Imperial College Health Partners which supports the North West London Sustainability and Transformation Partnership, the wider NHS, arm’s-length bodies, charities and private industry.

Speaker%20picture%20 %20Darren%20Spevick

Darren Spevick, Managing Partner, Eventum Partners and Chair of the EMIG Digital Health Special Interest Group

After completing a BSc in Sports Science, Darren went into applied human performance research before embarking in a career in healthcare / life science executive recruitment. Over the last 20 years, Darren has worked with most types of companies from pharma, biotech, CRO, medtech, health services, data and health tech. In 2016 he set up the EMIG Digital Health Special Interest Group where he brings digital companies and EMIG members together.

Terms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2020. MAP BioPharma Limited. All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

+44 (0) 1480 832360

MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281

VAT Group Registration Number GB 292 8576 52